This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

138 Resources
138 Resources
138 Resources
    Date
  1. This fact sheet provides an overview of the novel oral polio vaccine (nOPV) program, a consortium of PATH and partners that are working to advance novel vaccine candidates that will enable complete eradication and minimize the risk of polio making a comeback.
    Published: January 2021
    Type: Resource Page
  2. The Single-Dose HPV Vaccine Evaluation Consortium encompasses eight leading independent research institutions working together to collate and synthesize existing evidence and evaluate new data on the potential for single-dose HPV vaccination.
    Published: January 2021
    Type: Resource Page
  3. A synthesis of the full review on current, published evidence relevant to single-dose HPV vaccination. This includes immunogenicity, efficacy and effectiveness; identification of gaps in the evidence; and forthcoming evidence.
    Published: December 2020
    Type: Resource Page
  4. Switching from one vaccine product to another can have a significant impact on a country’s budget. For Palestine’s rotavirus vaccination program, a switch paid off.This brief describes an economic analysis conducted by PATH in partnership with the Rostropovich-Vishnevskaya Foundation and the Palestinian Ministry of Health to assess the economic implications of Palestine's switch from ROTARIX to ROTAVAC.
    Published: December 2020
    Type: Resource Page
  5. The primary objective of this review is to summarize and assess the current evidence that could support a change to a single-dose schedule of HPV vaccine. The review also aims to identify gaps that remain in determining whether a single dose could be sufficiently protective to have a major impact against HPV infection and its sequelae, within the context of immunization programs.
    Published: November 2020
    Type: Resource Page
Load more